Q1 2018 Trends in Biopharma Transactions Report

Locust Walk is a global transaction firm serving biopharma and medtech companies in the US, Europe, and Asia.​ Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2018 Trends in...

Q1 2018 Trends in Medtech Transactions Report

Locust Walk is a global transaction firm serving biopharma and medtech companies in the US, Europe, and Asia.​ Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2018 Trends in Medtech...

Q3 2017 Trends in Life Sciences Finance

Each quarter Locust Walk experts compile key statistics and trends on strategic transactions and financings. Our Q3 report uses the latest data to analyze current trends in the life science deal landscape. In this report you can find an overview and analysis of:...

Q2 2017 Trends in Life Science Finance

Our Q2 report analyzes current trends of 2017, and how life science strategic deal activity has been performing in recent years. In this report you can find an overview and analysis of: Biopharma public indices Biopharma IPOs Deal activity for strategic partnership...

Q1 2017 Trends in Biotech Finance

Our Q1 report analyzes current trends of 2017, and how life science strategic deal activity has been performing in recent years. In this report you can find an overview and analysis of: Biopharma public indices Biopharma IPOs Deal activity for strategic partnership...

2016 Market Conditions Report

Each quarter we compile key statistics and trends on strategic transactions and financing.  Our 2016 year-end report now includes highlights from the US, Japanese and European markets as well as biopharma and medtech sectors. Click here to download your free...